Different requirements for α-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases

European Journal of Immunology

Volumn 31, Issue 10, 2001, Pages 3101-3110

  Chiodoni, Claudia ^a   Stoppacciaro, Antonella ^b   Sangaletti, Sabina ^a   Gri, Giorgia ^a   Cappetti, Barbara ^a   Koezuka, Yasuhiko ^c   Colombo, Mario P ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c KIRIN BREWERY CO LTD   (Japan)

Author keywords

Galactosylceramide; IL 12; NK cell; NKT cell; Tumor immunity

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; BETA 2 MICROGLOBULIN; CD8 ANTIGEN; GALACTOSYLCERAMIDE; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 12; PROTEIN P40; RECOMBINANT INTERLEUKIN 12; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; FEMALE; IMMUNOCOMPETENCE; KILLER CELL; KNOCKOUT MOUSE; LIVER METASTASIS; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY;

ANIMALS; BETA 2-MICROGLOBULIN; COLONIC NEOPLASMS; FEMALE; GALACTOSYLCERAMIDES; INTERFERON TYPE II; INTERLEUKIN-12; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOMBINANT PROTEINS;

EID: 0034777510     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(2001010)31:10<3101::AID-IMMU3101>3.0.CO;2-8     Document Type: Article

References (31)

1. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides
2. Mouse CD1-specific NK1 T cells: Development, specificity, and function
3. + T cell development and early IL-4 production in CD1-deficient mice
4. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells
5. KRN7000, a novel immunomodulator, and its antitumor activities
6. Antitumor activities of combined treatment with a novel immunomodulator (2S, 3S, 4R)-1-O-(α-D-galactopyranosyl)-2-(N-hexa-cosanoylamino)-1, 3, 4-octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice
7. Treatment of hepatic metastases of the Colon26 adenocarcinoma wit an alpha-galactosylceramide, KRN7000
8. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
9. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells
10. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates it immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
11. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes
12. Interleukin-12: Role of interferon-gamma in IL-12 adverse effects
13. NKT cells are phenotypically and functionally diverse
14. + cells in the liver of mice
15. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
16. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production
17. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes
18. Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells
19. Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12
20. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide
21. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
22. Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12
23. + T cells in IL-12-induced immune response in vivo
24. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes
25. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
26. Immune suppression and skin cancer development: Regulation by NKT cells
27. + T cells and granulocytes colony-stimulating factor
28. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
29. Multiple defects of immune cell function in mice with disrupted interferon-γ genes
30. Experimental model for liver metastasis formation using Lewis lung tumor
31. Regression of an established tumor genetically modified to release granulocytes colony-stimulating factor requires granulocytes-T cell cooperation and T cell-produced interferon gamma